NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

52 hedge funds and large institutions have $22.9M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.27M
Puts
$1.57M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.92M
2
$2.77M
3
$2.27M
4
$1.26M
5
$1.16M
6
$903K
7
$851K
8
$740K
9
$678K
10
$622K
11
$555K
12
$531K
13
$484K
14
$435K
15
$419K
16
$318K
17
$316K
18
$292K
19
$284K
20
$270K
21
$258K
22
$251K
23
$183K
24
$172K
25
$169K